ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

OXALIPLATINUM

Active substance (INN) · ATC L01XA03 · 3 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
H006C	TUMORI NEUROENDOCRINE - TRATAMENT CU ANALOGI DE SOMATOSTATINĂ	In force	mentioned in the text	C1-G22	NO
L01BC59	COMBINATI (TRIFLURIDINUM + TIPIRACILUM)	In force	mentioned in the text	C2-P3	NO
L01XC08	PANITUMUMABUM	In force	mentioned in the text	C2-P3	NO
L01XC11-17	NIVOLUMABUM + DCI IPILIMUMABUM	In force	mentioned in the text	C2-P3	NO
L01XC18	PEMBROLIZUMABUM	In force	mentioned in the text	C2-P3	NO
L01XE27	IBRUTINIBUM	In force	mentioned in the text	C2-P3	NO
L01XX19	IRINOTECANUM (ONIVYDE PEGYLATED LIPOSOMAL)	In force	mentioned in the text	C2-P3	NO
L01XX44	AFLIBERCEPTUM	In force	mentioned in the text	C2-P3	NO
L037C	CETUXIMABUM	In force	mentioned in the text	C2-P3	NO

History: entries into and exits from protocols

Month	Type	Code	Protocol	Level
March 2026	Medicine added	L01XE27	IBRUTINIBUM	mentioned in the text

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
OXALIPLATIN ACCORD 5 mg/ml	CONC. PT. SOL. PERF.	5mg/ml	ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA	L01XA03	PR
OXALIPLATIN KABI 5 mg/ml	CONC. PT. SOL. PERF.	5mg/ml	FRESENIUS KABI ROMANIA S.R.L. - ROMANIA	L01XA03	PR
OXALIPLATINA AQVIDA 5 mg/ml	CONC. PT. SOL. PERF.	5mg/ml	AQVIDA GMBH - GERMANIA	L01XA03	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.